SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-22-016850
Filing Date
2022-11-08
Accepted
2022-11-08 16:03:00
Documents
75
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q chrs-20220930x10q.htm   iXBRL 10-Q 2407474
2 EX-31.1 chrs-20220930xex31d1.htm EX-31.1 14073
3 EX-31.2 chrs-20220930xex31d2.htm EX-31.2 14969
4 EX-32.1 chrs-20220930xex32d1.htm EX-32.1 12077
  Complete submission text file 0001558370-22-016850.txt   8530117

Data Files

Seq Description Document Type Size
5 EX-101.SCH chrs-20220930.xsd EX-101.SCH 59226
6 EX-101.CAL chrs-20220930_cal.xml EX-101.CAL 62253
7 EX-101.DEF chrs-20220930_def.xml EX-101.DEF 246458
8 EX-101.LAB chrs-20220930_lab.xml EX-101.LAB 448382
9 EX-101.PRE chrs-20220930_pre.xml EX-101.PRE 388473
69 EXTRACTED XBRL INSTANCE DOCUMENT chrs-20220930x10q_htm.xml XML 1458036
Mailing Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065
Business Address C/O DENNIS M. LANFEAR 333 TWIN DOLPHIN DR, SUITE 600 REDWOOD CITY CA 94065 (650) 649-3530
Coherus BioSciences, Inc. (Filer) CIK: 0001512762 (see all company filings)

IRS No.: 273615821 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36721 | Film No.: 221368779
SIC: 2836 Biological Products, (No Diagnostic Substances)